Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Aug, 17 2026
Apr, 30 2026
Sep, 4 2023
Nov, 14 2025
Aug, 4 2025